Go Pro

Brooks Moore & Associates Inc. Makes New $4.31 Million Investment in Proto Labs, Inc. $PRLB

Proto Labs logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Brooks Moore & Associates acquired 47,455 Proto Labs shares worth approximately $4.31 million, making up 1.9% of the fund’s portfolio. Institutional investors collectively own 84.54% of the company.
  • Proto Labs exceeded quarterly expectations, reporting $0.60 EPS versus the $0.53 consensus and $149.34 million in revenue, up 10.5% year over year. The company guided for third-quarter EPS of $0.56–$0.64.
  • Analysts maintain a generally bullish outlook, with the stock receiving an average “Buy” rating and an $89 price target, compared with a recent price of $80.20.
  • MarketBeat previews top five stocks to own in September.

Brooks Moore & Associates Inc. purchased a new stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 47,455 shares of the industrial products company's stock, valued at approximately $4,306,000. Proto Labs comprises approximately 1.9% of Brooks Moore & Associates Inc.'s holdings, making the stock its 17th largest position. Brooks Moore & Associates Inc. owned about 0.20% of Proto Labs as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Proto Labs during the second quarter worth about $317,581,000. XXEC Inc. boosted its holdings in Proto Labs by 2,060.4% in the second quarter. XXEC Inc. now owns 1,261,547 shares of the industrial products company's stock valued at $111,461,682,000 after acquiring an additional 1,203,154 shares during the last quarter. Rubric Capital Management LP increased its position in Proto Labs by 791.9% during the 2nd quarter. Rubric Capital Management LP now owns 1,034,171 shares of the industrial products company's stock valued at $41,408,000 after purchasing an additional 918,219 shares during the period. American Capital Management Inc. acquired a new stake in Proto Labs during the 2nd quarter valued at approximately $50,524,000. Finally, S Squared Technology LLC bought a new position in Proto Labs during the 2nd quarter worth approximately $23,484,661,000. Institutional investors and hedge funds own 84.54% of the company's stock.

Proto Labs Stock Up 1.7%

Shares of PRLB stock opened at $80.20 on Friday. The company has a market cap of $1.92 billion, a price-to-earnings ratio of 64.16 and a beta of 1.40. Proto Labs, Inc. has a 52 week low of $45.10 and a 52 week high of $93.00. The firm has a 50 day moving average of $80.46 and a 200-day moving average of $70.91.

Proto Labs (NYSE:PRLB - Get Free Report) last released its earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.07. The company had revenue of $149.34 million for the quarter, compared to the consensus estimate of $144.53 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. Proto Labs's quarterly revenue was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.41 EPS. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Analysts anticipate that Proto Labs, Inc. will post 1.46 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Needham & Company LLC upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 price target on the stock in a research report on Monday, August 3rd. Weiss Ratings cut shares of Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, August 18th. Benchmark lifted their target price on shares of Proto Labs from $70.00 to $91.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Wall Street Zen lowered shares of Proto Labs from a "strong-buy" rating to a "buy" rating in a report on Saturday, July 18th. Finally, Zacks Research upgraded shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $89.00.

Read Our Latest Analysis on PRLB

Insiders Place Their Bets

In other news, Director Sven Wehrwein sold 2,000 shares of the company's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the transaction, the director owned 32,505 shares in the company, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company's stock.

About Proto Labs

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

See Also

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines